Bristol-Myers under scrutiny by federal prosecutors

TedGriffith

Bristol-Myers Squibb said Wednesday the U.S. attorney in New Jersey has opened an inquiry into how the company handled accounting for inventory buildup at the wholesaler level. The news is just the latest blow for the drugmaker, which has previously said the Securities and Exchange Commission is also investigating the inventory issue. Shares of Bristol-Myers Squibb
BMY, +0.91%
fell 69 cents to $21.64 in recent dealings.

Have breaking news sent to your inbox. Subscribe to MarketWatch's free Bulletin emails. Sign up here.

Intraday Data provided by SIX Financial Information and subject to terms of use. Historical and current end-of-day data provided by SIX Financial Information. All quotes are in local exchange time. Real-time last sale data for U.S. stock quotes reflect trades reported through Nasdaq only. Intraday data delayed at least 15 minutes or per exchange requirements.